Anwar’s administration faces test in dealing with troubled GLC Pharmaniaga

The Malaysian pharma giant has 14 million unused Sinovac vaccines that has pulled down its finances. PHOTO: ST FILE
New: Gift this subscriber-only story to your friends and family

KUALA LUMPUR - Malaysia’s pharmaceutical firm Pharmaniaga is hoping for government help to sell its massive Covid-19 vaccine stockpile, in what could be a litmus test for the four-month-old Anwar Ibrahim administration in managing troubled government-linked companies (GLCs).

During the pandemic, the Malaysian government directly bought vaccines such as Pfizer and AstraZeneca from manufacturers. The government also allowed Pharmaniaga to exclusively import Sinovac vaccines from China. Malaysia also took part in the Covax programme supported by World Health Organisation to buy vaccines. 

Already a subscriber? 

Read the full story and more at $9.90/month

Get exclusive reports and insights with more than 500 subscriber-only articles every month

Unlock these benefits

  • All subscriber-only content on ST app and

  • Easy access any time via ST app on 1 mobile device

  • E-paper with 2-week archive so you won't miss out on content that matters to you

Join ST's Telegram channel and get the latest breaking news delivered to you.